170 related articles for article (PubMed ID: 15705945)
1. Renal haemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration.
Persson PB; Patzak A
Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i2-5. PubMed ID: 15705945
[TBL] [Abstract][Full Text] [Related]
2. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
Feldkamp T; Kribben A
Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
[TBL] [Abstract][Full Text] [Related]
3. Contrast-induced nephropathy.
Ray S; Dutta A
Indian Heart J; 2008; 60(2):133-8. PubMed ID: 19218722
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
[TBL] [Abstract][Full Text] [Related]
5. Contrast-induced nephropathy: the wheel has turned 360 degrees.
Thomsen HS; Morcos SK; Barrett BJ
Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
[TBL] [Abstract][Full Text] [Related]
6. Recent issues in contrast-induced nephropathy.
Kitajima K; Maeda T; Watanabe S; Sugimura K
Int J Urol; 2011 Oct; 18(10):686-90. PubMed ID: 21834851
[TBL] [Abstract][Full Text] [Related]
7. Contrast medium-induced nephropathy: strategies for prevention.
Massicotte A
Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
[TBL] [Abstract][Full Text] [Related]
8. Prevention of iodinated contrast-induced nephropathy.
Li JH; He NS
Chin Med J (Engl); 2011 Dec; 124(23):4079-82. PubMed ID: 22340345
[TBL] [Abstract][Full Text] [Related]
9. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
Fishman EK; Reddan D
Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
[TBL] [Abstract][Full Text] [Related]
10. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
11. Is angiotensin-converting enzyme inhibitor a contraindication for contrast-induced nephropathy prophylaxis? A review about its paradox.
Li X; Li T; Cong H
Cardiovasc Ther; 2012 Oct; 30(5):273-6. PubMed ID: 21884031
[TBL] [Abstract][Full Text] [Related]
12. A review of pharmacologic interventions to prevent contrast-induced nephropathy.
Lepor NE
Rev Cardiovasc Med; 2003; 4 Suppl 5():S34-42. PubMed ID: 14668708
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of contrast-induced nephropathy.
Wong PC; Li Z; Guo J; Zhang A
Int J Cardiol; 2012 Jul; 158(2):186-92. PubMed ID: 21784541
[TBL] [Abstract][Full Text] [Related]
14. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of contrast-induced nephropathy.
Tumlin J; Stacul F; Adam A; Becker CR; Davidson C; Lameire N; McCullough PA;
Am J Cardiol; 2006 Sep; 98(6A):14K-20K. PubMed ID: 16949376
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and therapy strategies for contrast-induced nephropathy.
Toprak O; Cirit M
Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085
[TBL] [Abstract][Full Text] [Related]
17. [Pathophysiology of contrast-induced nephropathy].
Guastoni C; De Servi S
G Ital Cardiol (Rome); 2009 Feb; 10(2):73-8. PubMed ID: 19348143
[TBL] [Abstract][Full Text] [Related]
18. How to avoid CIN: guidelines from the European Society of Urogenital Radiology.
Thomsen HS
Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i18-22. PubMed ID: 15705944
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
McCullough P
Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
[TBL] [Abstract][Full Text] [Related]
20. Contrast media-induced nephrotoxicity--questions and answers.
Morcos SK
Br J Radiol; 1998 Apr; 71(844):357-65. PubMed ID: 9659127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
